Showing 6061-6070 of 20929 results for "".
- New Horizons in Alzheimer's: Emerging Therapeutic Targets and Economic Challengeshttps://reachmd.com/news/new-horizons-in-alzheimers-emerging-therapeutic-targets-and-economic-challenges/2475253/Alzheimer’s disease progressively impairs patients’ cognition and independence, and clinicians are navigating both the emerging promise of disease-modifying targets and the economic constraints that may affect their implementation. Alt
- Scrutinizing Ticagrelor's Efficacy: Emerging Evidence and Alternativeshttps://reachmd.com/news/scrutinizing-ticagrelors-efficacy-emerging-evidence-and-alternatives/2475266/Ticagrelor’s established role in preventing thromboembolic events now faces scrutiny as inaccuracies in pivotal platelet
- Transforming Prostate Cancer Treatment Through Biomarkershttps://reachmd.com/news/transforming-prostate-cancer-treatment-through-biomarkers/2475261/Advancements in identifying specific biomarkers have transformed the landscape of aggressive prostate cancer treatment, offering personalized therapy options and improving patient outcomes. Urologic oncologists increasingly confront ca
- Harnessing TrypPROTACs and Switchable CAR-T Therapies in Precision Medicinehttps://reachmd.com/news/harnessing-trypprotacs-and-switchable-car-t-therapies-in-precision-medicine/2475239/Proteomics-driven innovations such as TrypPROTACs and switchable CAR-T therapies are currently in preclinical or early-phase trials, indicating a new era in precision medicine but not yet transforming standard clinical practice. Effect
- Adapting Allergy Management as Pollen Seasons Extend with Climate Changehttps://reachmd.com/news/adapting-allergy-management-as-pollen-seasons-extend-with-climate-change/2475242/As global temperatures rise, allergists confront the growing impact of longer pollen seasons, which drive increases in respiratory distress and demand new strategies for management. Clinicians are now grappling with an
- AI's Role in Ophthalmology: Balancing Promise with Evidence Gapshttps://reachmd.com/news/ais-role-in-ophthalmology-balancing-promise-with-evidence-gaps/2475233/AI’s promise for sharper diagnosis and tailored patient care in ophthalmology is tempered by unexpected blind spots in the evidence supporting its use. Regulatory bodies such as the FDA have approved AI models for eye care; however, th
- Biologic Therapies in Plaque Psoriasis: A Shift in Clinical and Economic Practicehttps://reachmd.com/news/biologic-therapies-in-plaque-psoriasis-a-shift-in-clinical-and-economic-practice/2475248/As biologic therapies increasingly define the therapeutic landscape for plaque psoriasis, their growing use highlights significant shifts in clinical and economic practice. Dermatologists now face the reality that
- Radiomics Models with PSMA PET/CT Outperform Mehralivand Grading in Prostate Cancerhttps://reachmd.com/news/radiomics-models-with-psma-petct-outperform-mehralivand-grading-in-prostate-cancer/2475240/Radiomics models based on PSMA PET/CT have demonstrated improved performance over the Mehralivand grading system in predicting extraprostatic extension in prostate can
- Biomarker-Driven Therapies Pioneer Personalized COPD Carehttps://reachmd.com/news/biomarker-driven-therapies-pioneer-personalized-copd-care/2475247/Recent FDA clearances and trial insights spotlight a shift in COPD management: biomarker-driven therapies and innovative inhalation solutions are forging personalized care strategies that target specific phenotypes and streamline disease cont
- Elevating Maternal Care: The Expansion of Midwifery Modelshttps://reachmd.com/news/elevating-maternal-care-the-expansion-of-midwifery-models/2475234/Midwifery models are increasingly being recognized as pivotal in enhancing maternal and perinatal outcomes, with the WHO midwifery care guidelines recommending midwives as primary care pr